Andrew Lerner

Andrew Lerner has extensive work experience in various roles related to business development, corporate development, and innovation. Andrew has held positions at companies such as Aktis Oncology, StrideBio, Inc, Rockridge Venture Law, Duke University, UNC Eshelman School of Pharmacy, and others. Their roles have included Associate Director, Business Development, Senior Manager in corporate and business development, Patent Agent, Program Director, and Innovation and Translation Fellow. Lerner's experience spans from academia to the biotechnology industry, showcasing a diverse skill set and expertise.

Andrew Lerner completed their Bachelor of Science in Chemistry at the University of California, Berkeley in 2010. Andrew then pursued a Doctor of Philosophy in Biochemistry and Biophysics at the University of North Carolina at Chapel Hill School of Medicine from 2013 to 2019. In 2021, Andrew participated in the Startup Fundamentals: Form + Fund Fellowship at the University of California, Berkeley School of Law. In addition to their formal education, they obtained multiple certifications in finance, law, and technology-related fields from various institutions.